IBRAMVIBART

UNII:	PRC4J48944
Type:	INGREDIENT SUBSTANCE
Formula:
Preferred Substance Name:	IBRAMVIBART
GSRS Full Record:	PRC4J48944 i

3031270-42-2
H-gamma1 heavy chain Homo sapiens (1-454) [VH (Homo sapiens IGHV3-21*07 (88.8%) -(IGHD) -IGHJ4*01 (92.9%), CDRIMGT [8.8.17] (26-33.51-58.97-113)) (1-124) -Homo sapiens IGHG1*03, G1m3, nG1m1 CH1 R120, CH3 E12, M14, 9-G1v78 CH3 L107 A114 (CH1 R120 (221) (125-222), hinge 1-15 (223-237), CH2 (238-347), CH3 E12 (363), M14 (365), M107>L (435), N114>A (441) (348-452), CHS (453-454)) (125-454)], (227-217')-disulfide with L-lambda2 light chain Homo sapiens (1'-218') [VLAMBDA (Homo sapiens IGLV1-40*01 (92.8%) -IGLJ1*01 (91.7%), CDR-IMGT [9.3.12] (26'-34'.52'-54'.91'-102')) (1'-112') -Homo sapiens IGLC2*01 (100%) (C-LAMBDA2) (113'-218')]; dimer (233-233'':236-236'')-bisdisulfide, produced in Chinese hamster ovary (CHO) cells, cell line CHO-K1, glycoform alfa
IBRAMVIBART [USAN]
Ibramvibart
Immunoglobulin G1 [435-leucine,441-alanine], anti-(severe acute respiratory syndrome coronavirus 2 spike glycoprotein receptor-binding domain) (human monoclonal VYD2311 γ1-chain), disulfide with human monoclonal VYD2311 λ-chain, dimer
VYD-2311
VYD2311
ibramvibart [INN]
immunoglobulin G1-kappa, anti-[severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike (S) protein, receptor binding domain (RBD)], Homo sapiens monoclonal antibody (Ibramvibart)

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

IBRAMVIBART

Synonyms and Mappings

Resources